Edition:
United States

Viveve Medical Inc (VIVE.OQ)

VIVE.OQ on NASDAQ Stock Exchange Capital Market

2.10USD
14 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.10
Open
$2.10
Day's High
$2.15
Day's Low
$2.05
Volume
26,909
Avg. Vol
41,631
52-wk High
$5.40
52-wk Low
$1.60

Latest Key Developments (Source: Significant Developments)

Viveve Medical Q3 Loss Per Share $0.39
Thursday, 8 Nov 2018 04:02pm EST 

Viveve Medical Inc ::VIVEVE REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.39.Q3 REVENUE $4.8 MILLION VERSUS I/B/E/S VIEW $4.5 MILLION.Q3 EARNINGS PER SHARE VIEW $-0.33 -- THOMSON REUTERS I/B/E/S.CASH AND CASH EQUIVALENTS WERE $20.1 MILLION AS OF SEPTEMBER 30, 2018.  Full Article

Viveve Submits VIVEVE II Clinical Study Safety Data To FDA
Tuesday, 3 Jul 2018 08:28am EDT 

July 3 (Reuters) - Viveve Medical Inc ::VIVEVE SUBMITS VIVEVE II CLINICAL STUDY 30-DAY PATIENT SAFETY DATA TO FDA.VIVEVE MEDICAL INC - NO SERIOUS ADVERSE EVENTS REPORTED IN SUBMISSION OF VIVEVE II CLINICAL STUDY 30-DAY PATIENT SAFETY DATA TO FDA.VIVEVE MEDICAL - FINAL STUDY RESULTS COULD SUPPORT A MARKETING APPLICATION FOR EXPANDED U.S. INDICATION FOR IMPROVEMENT OF SEXUAL FUNCTION IN WOMEN.  Full Article

Viveve Appoints Scott Durbin As Chief Executive Officer
Thursday, 10 May 2018 02:06pm EDT 

Viveve Medical Inc ::VIVEVE APPOINTS SCOTT DURBIN AS CHIEF EXECUTIVE OFFICER.VIVEVE MEDICAL INC - DURBIN'S APPOINTMENT FOLLOWS PATRICIA SCHELLER'S DECISION TO STEP DOWN FROM HER POSITION AS CHIEF EXECUTIVE OFFICER.VIVEVE MEDICAL INC - DURBIN WILL ALSO JOIN BOARD OF DIRECTORS.VIVEVE MEDICAL INC - SCHELLER WILL REMAIN ON VIVEVE BOARD OF DIRECTORS.VIVEVE MEDICAL - DURBIN'S APPOINTMENT FOLLOWS PATRICIA SCHELLER'S DECISION TO STEP DOWN FROM HER POSITION AS CEO.  Full Article

Viveve Announces Preliminary 2017 Fourth Quarter Results
Thursday, 4 Jan 2018 08:28am EST 

Jan 4 (Reuters) - Viveve Medical Inc ::VIVEVE ANNOUNCES PRELIMINARY 2017 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS AND PROVIDES 2018 REVENUE GUIDANCE.SEES FY 2018 REVENUE $22 MILLION TO $24 MILLION.SEES FY 2017 REVENUE $15.3 MILLION.FY2017 REVENUE VIEW $15.5 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $23.6 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Viveve Medical Inc files for mixed shelf of up to $50 million
Wednesday, 8 Nov 2017 05:17pm EST 

Nov 8 (Reuters) - Viveve Medical Inc :Viveve Medical Inc files for mixed shelf of up to $50 million .  Full Article

Viveve reports Q3 loss per share $0.50
Wednesday, 8 Nov 2017 04:02pm EST 

Nov 8 (Reuters) - Viveve Medical Inc :Viveve announces third quarter 2017 financial results.Q3 loss per share $0.50.Q3 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S.Q3 revenue $4.1 million versus i/b/e/s view $3.7 million.  Full Article

Viveve releases preliminary Q3 2017 financial results
Wednesday, 18 Oct 2017 08:28am EDT 

Oct 18 (Reuters) - Viveve Medical Inc :Viveve releases preliminary third quarter 2017 financial results.Viveve Medical- sees Q3 revenue from sale of 60 Viveve systems, about 2,700 disposable treatment tips, ancillary consumables to be about $4.1 million​‍​.  Full Article

Viveve gets regulatory nod to market Viveve System in Mexico
Tuesday, 17 Oct 2017 08:28am EDT 

Oct 17 (Reuters) - Viveve Medical Inc :Viveve announces regulatory approval for Viveve System in Mexico.Viveve Medical - received approval from Mexican regulatory authority, COFEPRIS, to market Viveve System in Mexico for treatment of vaginal introitus​.Viveve Medical Inc - working to submit IDE to FDA to conduct pivotal study on use of Viveve System for improvement in sexual function in women​.  Full Article

Viveve announces regulatory approval for Viveve System in Taiwan
Tuesday, 10 Oct 2017 08:28am EDT 

Oct 10 (Reuters) - Viveve Medical Inc :Viveve announces regulatory approval for Viveve System in Taiwan.Viveve Medical - got approval to market Viveve System from Taiwanese FDA for use in general surgical procedures for electrocoagulation,hemostasis​.Viveve - In process of submitting investigational device exemption to U.S FDA to conduct study on use of device for improvement in sexual function in women​.  Full Article

Viveve secures $30 million debt financing with CRG
Tuesday, 23 May 2017 04:02pm EDT 

May 23 (Reuters) - Viveve Medical Inc :Viveve secures $30 million debt financing with crg.Viveve medical inc - new credit facility consists of $20 million to be drawn at closing.Viveve medical inc - new credit facility alsoconsists of ability to access additional funding of up to an aggregate of $10 million.Viveve medical inc - term of loan is six years with first four years being interest only.  Full Article